Capital Management Associates NY Has $943,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Capital Management Associates NY has reduced its stake in UnitedHealth Group by 47.9%, now holding 1,800 shares worth approximately $943,000, making it the 28th largest position in their portfolio.
• Insider trading activity included CEO Stephen J. Hemsley purchasing 86,700 shares of the company, increasing his ownership by 14.63%.
• UnitedHealth Group announced a quarterly dividend of $2.21 per share, representing an annualized dividend of $8.84 and a yield of 3.39%.

Capital Management Associates NY cut its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 47.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,800 shares of the healthcare conglomerate's stock after selling 1,655 shares during the quarter. UnitedHealth Group accounts for 1.8% of Capital Management Associates NY's holdings, making the stock its 28th biggest position. Capital Management Associates NY's holdings in UnitedHealth Group were worth $943,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of UNH. Geode Capital Management LLC increased its stake in UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after purchasing an additional 319,515 shares in the last quarter. Capital International Investors increased its stake in UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after purchasing an additional 906,365 shares in the last quarter. Northern Trust Corp increased its stake in UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after purchasing an additional 1,058,488 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares during the last quarter. Finally, GAMMA Investing LLC boosted its position in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other news, CEO Stephen J. Hemsley purchased 86,700 shares of the business's stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

UNH has been the subject of a number of recent research reports. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. JPMorgan Chase & Co. increased their price objective on UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a report on Friday, June 20th. Barclays reissued an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Finally, Bank of America cut their price target on UnitedHealth Group from $350.00 to $300.00 and set a "neutral" rating for the company in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $378.95.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $5.36 during mid-day trading on Wednesday, reaching $266.43. The company had a trading volume of 22,302,965 shares, compared to its average volume of 13,886,933. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm has a market cap of $241.69 billion, a price-to-earnings ratio of 11.54, a PEG ratio of 1.37 and a beta of 0.45. The business's 50-day simple moving average is $298.96 and its 200 day simple moving average is $420.36.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $5.16 by ($1.08). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 EPS. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 3.32%. The ex-dividend date was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.